Electronic Membership now available
in Latin America!
Dear Colleague,
You asked, we delivered!
It is my pleasure to invite you to
join DIA as a Member. DIA’s electronic Membership provides with online
tools and digital access to an outstanding collection of tools and
resources to keep you ahead of the curve on the latest clinical
information, knowledge resources and regulatory news in the life sciences
and health care industry – all for just $35 a year.
|
|
|
In addition, as part of your membership you have access to
all the below tools and resources. To register online, click
here or to download a form, click
here. Enter your country and choose eMembership from the dropdown
list.
- eMembers-only registration
discounts on DIA Latin America conferences and over 200 DIA
offerings across the globe and online
- New! Members-only free archived
webinars. Take advantage of a hot topic webinar as a
complimentary member benefit – without leaving your desk
- New! DIA Online Member Directory.
Network locally and globally, share documents and discussions,
connect with colleagues and create your own network of colleagues
and industry thought leaders.
- Digital Subscription (6 issues
each) to:
- New in 2013! Subscription to Therapeutic Innovation
& Regulatory Science publication, DIA’s
peer-reviewed, scholarly journal (formerly the Drug Information Journal)
- Global Forum – your association digital news
magazine featuring practical tips, regulatory and global industry
updates
- Online Communities and DIA ConneX:
Members-only professional networking platform and Special
Interest Area Communities (SIACs) – DIA’s discipline specific
groups that share best practices and the latest information related
to your field
- DIA Online Career Center– your
source to find and list employment opportunities
If you have any questions regarding membership or joining,
please contact us at membership@diahome.org.
Sincerely,
Alejandro Bermudez-Del-Villar, MA/IBBD
Latin America & Global Program
Development Coordinator
Alejandro.Bermudez@diahome.org
|
|
|
|
|
No comments:
Post a Comment